As the global economy mends, the 2021 growth of Glioblastoma Multiforme (GBM) Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Glioblastoma Multiforme (GBM) Therapeutics market size is USD million in 2022 from USD 536.3 million in 2021, with a change of % between 2021 and 2022. The global Glioblastoma Multiforme (GBM) Therapeutics market size will reach USD 985.3 million in 2028, growing at a CAGR of 9.1% over the analysis period.
The United States Glioblastoma Multiforme (GBM) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glioblastoma Multiforme (GBM) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Glioblastoma Multiforme (GBM) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Glioblastoma Multiforme (GBM) Therapeutics players cover Merck, Roche, Arbor Pharmaceuticals, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Glioblastoma Multiforme (GBM) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- ChemOthersapy
- Targeted Drug Therapy
- Radiation Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Hospitals
- Clinics
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Merck
- Roche
- Arbor Pharmaceuticals
- Pfizer
- AbbVie
- Amgen
- Bristol-Myers Squibb
- Sun Pharmaceuticals
- Teva Pharmaceutical
- Emcure Pharmaceuticals
Global Glioblastoma Multiforme (GBM) Therapeutics Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size 2017-2028
2.1.2 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Glioblastoma Multiforme (GBM) Therapeutics Segment by Type
2.2.1 ChemOthersapy
2.2.2 Targeted Drug Therapy
2.2.3 Radiation Therapy
2.3 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
2.3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Glioblastoma Multiforme (GBM) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application
2.5.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
3 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Player
3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Players
3.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Glioblastoma Multiforme (GBM) Therapeutics by Regions
4.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Glioblastoma Multiforme (GBM) Therapeutics by Country (2017-2022)
7.2 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.2 Canada Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.3 Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.4 Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.2 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.3 Korea Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.4 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.5 India Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.6 Australia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.2 France Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.3 UK Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.4 Italy Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.5 Russia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.2 South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.3 Israel Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.4 Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.5 GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.6 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Type (2023-2028)
10.7 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Information
11.3.2 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Arbor Pharmaceuticals Main Business Overview
11.3.5 Arbor Pharmaceuticals Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Sun Pharmaceuticals
11.8.1 Sun Pharmaceuticals Company Information
11.8.2 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sun Pharmaceuticals Main Business Overview
11.8.5 Sun Pharmaceuticals Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 Emcure Pharmaceuticals
11.10.1 Emcure Pharmaceuticals Company Information
11.10.2 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Emcure Pharmaceuticals Main Business Overview
11.10.5 Emcure Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ChemOthersapy
Table 3. Major Players of Targeted Drug Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
Table 14. Glioblastoma Multiforme (GBM) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Glioblastoma Multiforme (GBM) Therapeutics
Table 44. Key Market Challenges & Risks of Glioblastoma Multiforme (GBM) Therapeutics
Table 45. Key Industry Trends of Glioblastoma Multiforme (GBM) Therapeutics
Table 46. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Merck Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 53. Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 54. Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Merck Main Business
Table 56. Merck Latest Developments
Table 57. Roche Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 58. Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 59. Roche Main Business
Table 60. Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Roche Latest Developments
Table 62. Arbor Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 63. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 64. Arbor Pharmaceuticals Main Business
Table 65. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Arbor Pharmaceuticals Latest Developments
Table 67. Pfizer Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 68. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. AbbVie Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 73. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 74. AbbVie Main Business
Table 75. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AbbVie Latest Developments
Table 77. Amgen Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 78. Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 79. Amgen Main Business
Table 80. Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Amgen Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Sun Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 88. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 89. Sun Pharmaceuticals Main Business
Table 90. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Sun Pharmaceuticals Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 93. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Teva Pharmaceutical Latest Developments
Table 97. Emcure Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 98. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 99. Emcure Pharmaceuticals Main Business
Table 100. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Emcure Pharmaceuticals Latest Developments
List of Figures
Figure 1. Glioblastoma Multiforme (GBM) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Glioblastoma Multiforme (GBM) Therapeutics in Hospitals
Figure 8. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Glioblastoma Multiforme (GBM) Therapeutics in Clinics
Figure 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Glioblastoma Multiforme (GBM) Therapeutics in Others
Figure 12. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Glioblastoma Multiforme (GBM) Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Glioblastoma Multiforme (GBM) Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Size 2023-2028 ($ Millions)
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
